Events

A Novel Approach in Solid Tumors: Updates on Alpha Tau’s Recent and Upcoming Alpha DaRT Trials

June 27, 2022

Join us for the Hybrid Alpha Tau KOL Breakfast Event, which will feature presentations from Key Opinion Leaders (KOLs) Michael J. Zelefsky, MD (Memorial Sloan Kettering Cancer Center), Mark D’Andrea, MD (University Cancer Centers) and Robert Den, MD (Alpha Tau’s Chief Medical Officer) who will discuss the science behind Alpha Tau’s therapy (the Alpha DaRT radiation technology) and its clinical…

Read More

ChromDex: The Transforming Benefits of Nicotinamide Riboside, Featuring Dr. Charles Brenner

June 27, 2022

The webinar will feature a presentation from Key Opinion Leader (KOL) Charles Brenner, PhD (City of Hope National Medical Center) who will discuss the latest research on Nicotinamide Riboside (NR) and its many benefits as a precursor to Nicotinamide Adenine Dinucleotide (NAD). NAD is the central catalyst to multiple metabolic processes and a critical ally to resilience and…

Read More

MediWound EscharEx Investor Breakfast

June 23, 2022

Join us for the MediWound EscharEx Investor Day, featuring presentations by Key Opinion Leaders (KOLs) John C. Lantis, M.D. (Mount Sinai West Hospital and Icahn School of Medicine), Cyaandi R. Dove, D.P.M. (Advanced Wound & Ankle Center, Las Vegas), Robert J. Snyder, D.P.M., M.Sc. (Barry University) and Kevin Feng (Oliver Wyman). These external experts will discuss the current wound…

Read More

LifeSci Partners Genetic Medicines Symposium

June 22, 2022

LifeSci Partners is hosting our 2nd Annual virtual Genetic Medicines Symposium on June 28th and 29th and will consist of virtual discussions with key opinion leaders (KOLs), as well as presentations/fireside chats with 30+ public and private companies focused on the development of genetic medicines. The potential of genetic medicines has never been greater, spanning…

Read More

Science37: The Operating System that enables Hybrid/Agile Clinical Trials: Accelerating Timelines & Optimizing Cost Savings

June 21, 2022

The traditional clinical trial model has not changed significantly in > 60 years. This event will feature how Science37’s decentralized clinical trials model is disrupting the traditional model by enabling Sponsors to achieve a shorter trial start-up, accelerated patient enrollment, better retention, and more diverse participants resulting in maximized time and cost savings to accelerate breakthrough clinical research.…

Read More

Cidara Therapeutics: Research & Development Day

June 17, 2022

The virtual R&D day will feature a panel discussion with Key Opinion Leaders (KOLs) in oncology Ezra Cohen, MD, FRCPSC, FASCO (San Diego Center for Precision Immunotherapy), Perry Nisen, MD, PhD (CEO and Executive Chairman of Quanta), and with Les Tari, PhD (Cidara’s Chief Scientific Officer). The discussion will be focused on Cidara’s Cloudbreak® platform which couples potent inhibitors to…

Read More

Oncocyte: Expert Webinar on the role of DetermaIO and the Tumor Microenvironment in Clinical Practice

June 15, 2022

The webinar will feature presentations from Key Opinion Leaders (KOLs) Chiara Cremolini, MD, PhD (Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Italy) and Adam Brufsky, MD, PhD (University of Pittsburgh School of Medicine). Dr. Cremolini will provide an expert data overview on the ASCO 2022 poster session: An immune-related gene expression profile to…

Read More

Mesoblast Key Opinion Leader Event Series for Investors & Analysts: Chronic Low Back Pain due to Degenerative Disc Disease

June 13, 2022

The webinar will focus on the current treatment landscape and unmet medical need for patients with chronic low back pain (CLBP) due to degenerative disc disease, a condition associated with local inflammation in the disc. The webinar will feature presentations from Key Opinion Leaders (KOLs) Douglas P. Beall, MD, FIPP, FSIR, DAAPM (Clinical Radiology Oklahoma) and Hyun W. Bae,…

Read More

Recce Pharmaceuticals’ Expert KOL Webinar: How R327 is leading the way as a potential, robust solution to Sepsis and Superbugs

June 2, 2022

The event will feature a presentation from Key Opinion Leader Thomas Heymann (President & CEO of Sepsis Alliance, USA), who will discuss the current treatment landscape and unmet medical need in treating patients with sepsis. Sepsis patient advocate Mary Millard (International Speaker, Hospital Infections & Prevention) will speak about her journey, the unmet need, and the current standard of…

Read More

Please join us for the third episode in ASLAN Pharmaceuticals’ A4 webinar series, Aspects of Atopic Dermatitis and ASLAN004

June 2, 2022

This third and final webinar in ASLAN’s A4 webinar series, “Dialogues with International Thought Leaders in Dermatology” will feature a presentation by Key Opinion Leader (KOL), Peter A Lio, MD, Clinical Assistant Professor at Northwestern University, who will share examples of patient journeys in atopic dermatitis (AD) and highlight the unmet medical needs, patient co-morbidities and limitations…

Read More